Environmental Isolation of Circulating Vaccine-Derived Poliovirus After Interruption of Wild Poliovirus Transmission - Nigeria, 2016

被引:0
|
作者
Etsano, Andrew [1 ]
Damisa, Eunice [1 ]
Shuaib, Faisal [2 ]
Nganda, Gatei Wa [3 ]
Enemaku, Ogu [4 ]
Usman, Samuel [5 ]
Adeniji, Adekunle [6 ]
Jorba, Jaume [7 ]
Iber, Jane [7 ]
Ohuabunwo, Chima [3 ]
Nnadi, Chimeremma [3 ]
Wiesen, Eric [3 ]
机构
[1] Natl Primary Hlth Care Dev Agcy, Abuja, Nigeria
[2] Bill & Melinda Gates Fdn, Seattle, WA USA
[3] CDC, Global Immunizat Div, Atlanta, GA 30333 USA
[4] Nigeria Off, United Nations Childrens Fund, Abuja, Nigeria
[5] CORE Grp Partners Project, Abuja, Nigeria
[6] Univ Ibadan, Coll Med, Div Virol, Ibadan, Nigeria
[7] CDC, Polio & Picornavirus Lab Branch, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
来源
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2016年 / 65卷 / 30期
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
What is known about this topic? The last case of wild poliovirus transmission in Nigeria was reported in July 2014. The country was officially removed from the list of countries with endemic wild poliovirus transmission in September 2015. What is added by this report? In April 2016, a laboratory-confirmed isolate of circulating vaccine-derived poliovirus type 2 (cVDPV2), a genetic variant of the vaccine virus with the potential to cause paralysis, was reported from a sewage effluent site in Borno, a state in northeastern Nigeria with international boundaries. Years of armed insurgency in Borno have led to reduced polio vaccination and surveillance activities, resulting in a population of underimmunized children. The Nigeria National Polio Emergency Operations Center activated an outbreak response that included supplemental immunization activities (SIAs), a retrospective search for acute flaccid paralysis (AFP) cases, and enhanced environmental surveillance. Approximately 1 million children were vaccinated in the first SIA round, and 13 previously unreported AFP cases were identified. What are the implications for public health practice? Strategies for increasing vaccination coverage, including deployment of innovative approaches for reaching children in conflict-affected areas, are needed to prevent VDPV and other vaccine preventable disease (VPD) outbreaks. Strengthening surveillance is an urgent priority. Closer coordination of polio eradication activities between state and national jurisdictions in the region should be considered to prevent the potential spread of cVDPV and other VPDs across international boundaries.
引用
收藏
页码:770 / 773
页数:4
相关论文
共 50 条
  • [1] Implications of a Circulating Vaccine-Derived Poliovirus in Nigeria.
    Jenkins, Helen E.
    Aylward, R. Bruce
    Gasasira, Alex
    Donnelly, Christl A.
    Mwanza, Michael
    Corander, Jukka
    Garnier, Sandra
    Chauvin, Claire
    Abanida, Emmanuel
    Pate, Muhammad Ali
    Adu, Festus
    Baba, Marycelin
    Grassly, Nicholas C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25): : 2360 - 2369
  • [2] Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model
    Gavrilin, GV
    Cherkasova, EA
    Lipskaya, GY
    Kew, OM
    Agol, VI
    JOURNAL OF VIROLOGY, 2000, 74 (16) : 7381 - 7390
  • [3] Vaccine-derived poliovirus outbreak in Nigeria
    Guy, Sara
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2008, 1 (01) : 9 - +
  • [4] Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
    Tebbens, Radboud J. Duintjer
    Thompson, Kimberly M.
    BMC INFECTIOUS DISEASES, 2015, 15
  • [5] Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
    Radboud J. Duintjer Tebbens
    Kimberly M. Thompson
    BMC Infectious Diseases, 15
  • [6] Vaccine-derived poliovirus cases exceed wild types
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2019, 19 (02): : 140 - 140
  • [7] Implications of a Circulating Vaccine-Derived Poliovirus in Nigeria (vol 362, pg 2360, 2010)
    Jenkins, Helen E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (13): : 1290 - 1290
  • [8] Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
    Iliyasu, Zubairu
    Verma, Harish
    Craig, Kehinde T.
    Nwaze, Eric
    Ahmad-Shehu, Amina
    Jibir, Binta Wudil
    Gwarzo, Garba Dayyabu
    Gajida, Auwalu U.
    Weldon, William C.
    Oberste, M. Steven
    Takane, Marina
    Mkanda, Pascal
    Muhammad, Ado J. G.
    Sutter, Roland W.
    VACCINE, 2016, 34 (42) : 5125 - 5131
  • [9] Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication
    Tebbens, Radboud J. Duintjer
    Pallansch, Mark A.
    Kew, Olen M.
    Caceres, Victor M.
    Jafari, Hamid
    Cochi, Stephen L.
    Sutter, Roland W.
    Aylward, R. Bruce
    Thompson, Kimberly M.
    RISK ANALYSIS, 2006, 26 (06) : 1471 - 1505
  • [10] Wild and vaccine-derived poliovirus circulation, and implications for polio eradication
    Lopalco, P. L.
    EPIDEMIOLOGY AND INFECTION, 2017, 145 (03): : 413 - 419